Skip to main
RDHL
RDHL logo

RedHill Biopharma (RDHL) Earnings Dates & Reports

RedHill Biopharma (RDHL) Most Recent Earnings

Report DateJun 23, 2022
Period EndingQ1 2022
Est. EPS-$230
Actual EPS-$300
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RedHill Biopharma (RDHL) Earnings per Share (EPS) History

Signup for full access
Browse free

RedHill Biopharma (RDHL) Latest Earnings

The value each RDHL share was expected to gain vs. the value each share gained.

RedHill Biopharma (RDHL) reported its most recent earnings on Jun 23, 2022 for Q1 2022, posting earnings per share (EPS) of -$300. This exceeded analysts' expectations of -$230 by 30.43%, marking a Miss.

For comparison, RedHill Biopharma reported EPS of -$50 in the same quarter last year.

The company is expected to announce its next earnings report on 04/08/2024, with analysts projecting an EPS of $0.

RedHill Biopharma (RDHL) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2023Apr 8, 2024
Next earnings call Apr. 8, 2024
Q2 2023Aug 17, 2023
$2.25
DeckReportListen
Q1 2023Jun 12, 2023
-$1.25
Q4 2022Apr 28, 2023
Next earnings call Apr. 8, 2024
Q3 2022Nov 29, 2022
-$60.00
View all

RedHill Biopharma (RDHL) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the RedHill Biopharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 17, 2023
Jun 12, 2023
Apr 28, 2023
Nov 29, 2022

RedHill Biopharma (RDHL) Earnings FAQs

RedHill Biopharma (RDHL) last reported earnings on Jun 23, 2022 for Q1 2022, posting an EPS of -$300, which Miss the estimate of -$230 by 30.43%.

For Q1 2022, RedHill Biopharma (RDHL) reported an EPS of -$300, missing analysts' estimate of -$230 by 30.43%.

For Q1 2022, RedHill Biopharma (RDHL) Miss expectations with an actual EPS of -$300 vs. an estimated EPS of -$230.

Following the last earnings report on Jun 23, 2022, RedHill Biopharma (RDHL)'s stock price moved — from — to —.

The next RedHill Biopharma (RDHL) earnings call is scheduled for Apr. 8, 2024, where executives will discuss financial results and outlook.

RedHill Biopharma (RDHL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.